The recognized prognostic features in non-metastatic, node-positive breast cancer that influence treatment decisions and outcome include patient age, tumor size, number and percentage of positive nodes, tumor grade, hormone receptor status and Her-2 status. Here, NR4A1 is linked to neoplasm.